Cryo-EM Reveals How Cas12a Uses a DNA Guide to Hunt RNA Targets

The CRISPR world has long been organized around a simple division of labor: some Cas enzymes are steered by RNA guides to cut DNA, while others are loaded with DNA guides to find RNA. That second group, the DNA-guided strands of the CRISPR family, has remained far less understood at the structural level, even though it includes Cas12a, one of the most widely used tools in genome editing. Now a team led by Ocampo and Orosco has captured the most intimate portrait yet of this molecular machine, reporting in Nature Structural & Molecular Biology a cryo-electron microscopy structure of Acidaminococcus sp. Cas12a bound simultaneously to a pseudo-DNA guide and an RNA target. The image resolves a puzzle that has shadowed the field for a decade: how an enzyme built to read DNA instructions can still recognize, verify and destroy an RNA molecule with exquisite precision.

The structure shows that the answer lies in a strategy biologists describe as structural mimicry. When Cas12a takes up its DNA guide, the complex does not merely carry the guide as a passive address label. Instead, the enzyme and the guide together fold into a shape that persuades the incoming RNA target that it has met a compatible partner. The guide strand and parts of the protein scaffold arrange themselves into a geometry that resembles the duplex the RNA would normally form, allowing the RNA to thread into the complex and pair with the guide as though it were engaging a conventional nucleic-acid partner. In other words, the system speaks RNA’s language while carrying DNA’s script.

To appreciate why this matters, it helps to recall what makes Cas12a unusual among CRISPR nucleases. Unlike Cas9, which requires two separate RNA molecules to form its active guide and creates blunt cuts in DNA, Cas12a needs only a single short RNA guide, recognizes a distinct class of protospacer-adjacent motifs, and cuts DNA in a staggered fashion that leaves overhanging ends prized by genome engineers. Cas12a also belongs to the subset of CRISPR effectors whose natural guide can be encoded in DNA, and once activated by a matching target it unleashes indiscriminate collateral cutting of nearby single-stranded nucleic acids, a behavior that underpins a growing portfolio of diagnostic tests. Every one of those applications depends on the same underlying event: the correct pairing of the guide with the intended target inside the enzyme’s grip.

The newly determined structure captures that event in remarkable detail. Acidaminococcus sp. Cas12a is seen cradling the pseudo-DNA guide in its central channel, with the guide’s seed region, the stretch of sequence that makes first contact with a prospective target, held in an ordered conformation that pre-organizes it for recognition. When the RNA target arrives, it threads through the complex and pairs with the guide, and the resulting hybrid duplex sits within a pocket lined with positively charged residues that stabilize the intertwined strands. Around this core, the protein domains that had been clamped open in the absence of a target rearrange into a catalytically competent architecture, snapping the enzyme into its cutting mode. The structure therefore presents both the resting and the engaged states of recognition in a single frozen moment.

What stands out most is how the pseudo-DNA guide participates in the deception. In related systems, RNA guides form extensive pairing interactions with the protein that keep them in the correct register. Here, the DNA guide relies on a hybrid strategy: parts of it mimic the conformation that an RNA guide would adopt, while the protein supplies compensatory contacts that read DNA’s distinctive chemical features, including the absence of the 2′-hydroxyl groups that decorate RNA. The researchers show that this arrangement allows the complex to present a target-binding surface that is effectively indistinguishable, in shape and charge distribution, from the surface presented by RNA-guided relatives. The RNA target, encountering this surface, binds and pairs with a partner that is chemically DNA but structurally fluent in RNA.

This mimicry extends to the catalytic heart of the enzyme. Cas12a’s nuclease activity depends on the RuvC domain, a processing module shared with other members of the CRISPR-Cas superfamily. In the new structure, the RuvC active site is positioned relative to the guide-target duplex in a way that mirrors its placement in RNA-guided complexes, confirming that the downstream cutting machinery does not care whether the guide is made of DNA or RNA. What matters is the geometry of the duplex delivered to it. By achieving that geometry through mimicry, Acidaminococcus Cas12a solves a chemical problem that would otherwise seem insurmountable: a DNA guide cannot form the same Watson-Crick interactions with the protein that RNA guides use, yet it must produce the same structural outcome.

The biological logic of such a system is thought to trace back to the evolutionary history of CRISPR effectors. Many researchers believe that the ancestral defense machines were RNA-guided, targeting the genetic material of viruses directly, and that DNA-guided variants emerged as immune systems shifted toward attacking DNA genomes. The new structure offers a snapshot of how that transition could be engineered by evolution without redesigning the whole enzyme: keep the recognition and cutting apparatus intact, and evolve the guide-binding channel so that a DNA guide is chaperoned into an RNA-like conformation. Structural mimicry, in this view, is not a curiosity but an economical evolutionary patch, and the pseudo-DNA guide captured in the structure may itself represent an intermediate stage in that ongoing molecular negotiation.

For technologists, the structure arrives as something closer to a blueprint than a curiosity. Genome editing with Cas12a is already routine in laboratories, and its single-guide simplicity, compact size and staggered cuts have made it a favorite for applications ranging from agriculture to therapeutic development. But rational engineering of Cas12a, whether to alter its motif preferences, improve its specificity, retune its collateral activity for diagnostics, or expand the range of sequences it can target, has been constrained by incomplete knowledge of how the DNA guide and the RNA target actually sit inside the enzyme. By showing precisely which residues cradle the guide, which contacts read the target, and which conformational changes license cutting, the structure gives engineers a map of the interaction surfaces they can mutate deliberately rather than by trial and error.

The diagnostic implications may be especially immediate. Cas12a-based assays, which detect pathogens or disease sequences by coupling target recognition to a fluorescent collateral-cutting reaction, depend critically on the sensitivity and specificity of the initial guide-target pairing. Understanding how a DNA guide presents itself to an RNA target, and how mismatches are sensed within the duplex, opens the door to designing guides and protein variants that discriminate more sharply between true targets and near matches, reducing false positives that have complicated real-world deployment. It also suggests routes to building entirely new guide chemistries: if the enzyme tolerates a pseudo-DNA guide, other modified nucleic acids might be accommodated within the same channel, each tuned for stability or detection chemistry.

Therapeutic engineering stands to gain as well. Cas12a’s relatively compact size makes it deliverable in gene-therapy vehicles that struggle to carry bulkier nucleases, and a validated atomic model of its target-recognition state enables computational screening of variants before any test tube is touched. Researchers seeking to minimize off-target editing can now ask structural questions that were previously unanswerable: which protein contacts relax the specificity of pairing, and which lock the seed region into a demanding standard. The same map can guide the design of anti-CRISPR or regulatory proteins that jam the recognition interface, offering a way to switch editing on or off in living systems.

Like any single structure, the model of Acidaminococcus Cas12a bound to a pseudo-DNA guide and RNA target is one frame in what is certainly a dynamic process. The enzyme undergoes further rearrangements during target cleavage and product release that remain to be visualized, and different Cas12a homologs may solve the DNA-guided recognition problem with variations on the theme revealed here. But the central finding is unlikely to change: the division between RNA-guided and DNA-guided CRISPR systems is thinner than it appears. At the level of three-dimensional architecture, the two families speak the same structural language, and one has been caught in the act of translation. That translation, now legible at near-atomic resolution, is precisely the kind of insight from which the next generation of CRISPR tools will be built.

Subject of Research: Cryo-EM structure of Acidaminococcus sp. Cas12a bound to a pseudo-DNA guide and RNA target

Article Title: Architecture of a DNA-guided Cas12a

Article References: Architecture of a DNA-guided Cas12a. (n.d.). https://doi.org/10.1038/s41594-026-01894-5

Image Credits: AI Generated

DOI: 10.1038/s41594-026-01894-5

Keywords: Cas12a, CRISPR, cryo-electron microscopy, structural mimicry, DNA-guided recognition, RNA target, gene editing, Acidaminococcus, nuclease, molecular structure, biotechnology, diagnostics